Obama's budget shortens biologic exclusivity, cuts drug spending

04/11/2013 | Medical Marketing & Media · In-PharmaTechnologist.com

President Barack Obama's budget proposal would reduce biologic exclusivity from 12 years to seven, and it includes more than $160 billion in reduced spending that affects drugmakers. The plan would increase discounts for branded medications under Medicare Part D and reduce prices for drugs for people eligible for both Medicare and Medicaid.

View Full Article in:

Medical Marketing & Media · In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC